Vutrisiran
Vutrisiran (ALN-TTRsc02) is a liver-directed, investigational, small interfering ribonucleic acid (siRNA) agent. Vutrisiran can be used for transthyretin (TTR) -mediated amyloidosis research[1].
Product Specifications
CAS Number
1867157-35-4
Product Name Alternative
ALN-TTRsc02
UNSPSC
12352208
Target
Small Interfering RNA (siRNA) ; Transthyretin (TTR)
Type
Oligonucleotides
Related Pathways
Epigenetics; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/vutrisiran.html
Purity
97.37
Solubility
H2O : ≥ 20 mg/mL
Smiles
[Vutrisiran]
Molecular Formula
C530H715F9N171O323P43S6
Molecular Weight
16345.00
References & Citations
[1]Bahru A Habtemariam, et al. Single-Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N-acetylgalactosamine-Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects. Clin Pharmacol Ther. 2021 Feb;109 (2) :372-382.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Oligonucleotides
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
199251 1 Pack (1 Panel (s) x 1 Pack)
M/PIC280/NT/TM-DIA200-1 Personal Protection (PPE) Signs & Labels (Adhesive)
Sign In for Pricing
View Details 
TL314251V 500 µL Each
CA8 Human shRNA Lentiviral Particle (Locus ID 767)
Sign In for Pricing
View Details 
042675-HRP 200 µL
TC10, ID (RHOQ, ARHQ, RASL7A, TC10, Rho-related GTP-binding protein RhoQ, Ras-like protein TC10, Ras-like protein family member 7A) (Azide free) (HRP) discontinued
Sign In for Pricing
View Details